BDBM504435 N-(3-(4-((S)-16-((2S,4R)-4- hydroxy-2-((4-(4- methylthiazol-5- yl)benzyl)carbamoyl) pyrrolidine-1-carbonyl)-17,17- dimethyl-14-oxo-3,6,9,12- tetraoxa-15- azapentadecyl)piperazin-1- yl)-1-(5-methylpyridin-2-yl)- 1H-pyrazol-5- yl)pyrazolo[1,5- a]pyrimidine-3-carboxamide::US11065231, Example 28

SMILES Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN2CCN(CC2)c2cc(NC(=O)c3cnn4cccnc34)n(n2)-c2ccc(C)cn2)C(C)(C)C)cc1

InChI Key InChIKey=KSHKPUCRKCDBQT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 504435   

TargetInterleukin-1 receptor-associated kinase 4(Human)
Arvinas Operations

US Patent
LigandPNGBDBM504435(N-(3-(4-((S)-16-((2S,4R)-4- hydroxy-2-((4-(4- meth...)
Affinity DataIC50: 650nMAssay Description:A Z′-Lyte assay based on a fluorescence resonance energy transfer (FRET) readout was developed for measuring IRAK4-dependent phosphorylation of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2021
Entry Details
US Patent